Primary CNS Lymphoma treatment and diagnostics abroad

Primary central nervous system lymphoma is a lymphoma arising in the brain, spinal cord, surrounding fluid spaces or eyes without systemic lymphoma at diagnosis. Most cases are B-cell lymphomas. It differs from glioma, brain metastases and lymphoma elsewhere in the body that also involves the nervous system. Symptoms may include changes in thinking, weakness, imbalance, seizures or visual problems, but these findings can have other causes. Accurate classification is essential before treatment is selected.

A specialist team coordinates neurological assessment, imaging, usually tissue diagnosis and tests to assess disease beyond the nervous system. Biopsy timing and corticosteroid use need particular care because steroids can affect diagnostic findings. Do not start, stop or change prescribed steroids independently. Treatment usually centres on medicines able to reach the central nervous system, with further therapy chosen individually. Prepare original scans, pathology and medication records for a consultation. New severe neurological symptoms require urgent local care rather than waiting for travel.

Confirming the diagnosis and extent

MRI, commonly with contrast, helps locate disease and plan investigation. Imaging can resemble glioma, metastasis or infection and cannot establish every diagnosis. The team usually obtains tissue for specialist pathology, often through a stereotactic biopsy planned with neurosurgical specialists. Extensive tumour removal is not the usual initial treatment pathway.

Assessment looks for lymphoma outside the nervous system to distinguish primary from secondary CNS disease. Eye examination may be relevant even without obvious visual symptoms. Cerebrospinal fluid testing is considered when clinically appropriate and safe; lumbar puncture requires attention to pressure and other risks. The investigations depend on the presentation and existing results.

Corticosteroids and biopsy planning

Corticosteroids can reduce swelling and lymphoma cells, which may make a biopsy less informative. When clinically safe, specialists try to obtain diagnostic tissue before giving them. Urgent symptoms can change priorities, so the treating team must balance diagnostic needs and immediate safety. Tell the team exactly which steroids you have received, with doses and dates; do not independently alter treatment.

Treatment and neurological function

Care is coordinated by clinicians experienced in lymphoma and neuro-oncology. High-dose methotrexate-based treatment is commonly central to the plan, sometimes with other chemotherapy and antibody treatment. Kidney function, general fitness, immune status and medicine interactions affect suitability and monitoring.

Further treatment may include selected high-dose therapy with autologous stem-cell support or radiotherapy. Benefits and toxicity require individual discussion. Brain radiation can affect thinking and memory, so its role and timing are carefully considered. Relapsed disease needs reassessment; additional medicines or a clinical trial may be discussed according to the case.

Preparation and continuing support

Record neurological changes, steroid exposure, all medicines and any immune-suppressing condition or treatment. Send original MRI files, pathology materials where requested and previous lymphoma records. Confirm whether current symptoms make travel appropriate, what the estimate covers and who will handle urgent deterioration.

Follow-up considers recurrence, cognition, mobility, vision and treatment effects. Agree rehabilitation, support at home and responsibility for reviewing scans and blood tests. A first seizure, reduced consciousness or rapidly worsening neurological symptoms needs urgent medical assessment locally.

Frequently asked questions

Is CNS lymphoma the same as glioma?

No. The cells of origin and treatment pathways differ; scans alone may not distinguish them reliably.

Should I stop steroids before the consultation?

No. Contact the treating team for instructions. Biopsy and symptom control must be coordinated safely.

Does every patient need brain tumour removal?

No. Biopsy commonly establishes the diagnosis, while lymphoma-directed medicines are central to treatment.

Can further care continue at home?

Ask both teams to agree monitoring, rehabilitation, prescriptions and urgent contacts before a trip.